Introduction Novartis Advisory Board meets with six National Psoriasis Patient Organisations to address patient relevant endpoints in psoriasis clinical trials. Where in the process? – Phase III When does...
Introduction An example of patient involvement looking at a case report on Phase III patient involvement in an advisory board comprising six expert GYN oncology nurses from across Europe...
Transcription My name is Dániel Végh. I’m coming from Hungary and I’m here to represent patients with diabetes from Hungary, but also Europe and global. My role is...
Transcription My name is Souzi Makri, I come from Cyprus. I’m an expert patient, I’m involved with the Cyprus League Against Rheumatism. I’m a member of the board,...
Introduction This EUPATI Mini-course starter kit is designed for patient involvement in health technology assessment regulation. This EUPATI Mini-course starter kit is based on content derived from the...
Herbal medicines are based on extracts from plants or parts of plants that have healing properties. They have been used for hundreds of years and can be seen as...
During the target selection step of the medicines development process, scientists choose which abnormal process to focus on and correct in order to treat an illness.
When performing a critical reading of clinical study results, the reader should take relevant information into account from the best available sources and should consider questions about the reliability,...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
